SeaStar Medical Holding Corporation heads into its Q1 2026 earnings report — due after the close on May 14 — with short sellers sharply rebuilding positions and the lending market tightening at an accelerating pace.
The most striking development this week is the speed of the short rebuild. Short interest has nearly doubled over the past month, climbing 86% to roughly 262,000 shares, or 0.73% of the free float. On its own, that absolute level is low. But the pace tells a different story: shorts rose 32% in the past week alone, the sharpest weekly acceleration in the 30-day window. The ORTEX short score has moved in lockstep, climbing from 55.7 ten days ago to 62.7 today — approaching the upper range for a micro-cap name in this sector. That trajectory matters more than the absolute percentage.
The borrow market confirms the move has substance. Availability has tightened sharply: the lending pool utilization rate jumped from 57% to 80% in a single week, moving to its highest level in the recent period and approaching the 52-week peak of 88.5%. Short sellers are consuming available borrow fast. Cost to borrow has edged up to 7.5% — modest in absolute terms but up 3% on the week, continuing a trend that reversed a prior softening in April. The combination of rising shorts, rising utilization, and rising borrow costs all pointing in the same direction is unusual for a stock at this market cap.
The equity rally runs counter to the positioning picture. The stock is up 10% on the week and 30% over the past month, closing at $4.84. The 101% year-to-date gain has left the company trading at a market cap of roughly $19 million — a tiny float where headline flows can move the price substantially. The analyst community last set a mean price target of $9.00, which would imply significant upside from current levels, but that data is from February 2026 and cannot be treated as current. The only meaningful forward reference is the RSI14 at 62.5 — momentum positive but not yet at overheated levels.
The earnings history here is relevant context. The March 2026 print triggered a 25% one-day jump and a 59% five-day move. The prior event delivered a 30% one-day surge and a 64% five-day rally. Two consecutive large post-earnings pops have drawn short sellers back into the name ahead of the third print — a pattern that makes the borrow tightening particularly pointed. Whether that positioning reflects hedging by longs, or directional bearish conviction from new entrants, the data cannot confirm. What it establishes clearly is that demand for borrow has accelerated materially in the days immediately before results.
The earnings event is the thing to watch. With short interest doubling in a month, utilization approaching annual highs, and the stock already up sharply on the year, the range of outcomes around Thursday's report — and the reactions in the lending market afterward — will set the tone for the next leg.
See the live data behind this article on ORTEX.
Open ICU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
